Germany · Delayed Price · Currency is EUR LivaNova Company Description
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products and therapies for neurological and cardiac conditions worldwide.
The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannulae, connect, and other related accessories.
The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve; and devices that deliver neuromodulation therapy for treating difficult-to-treat depression and drug-resistant epilepsy.
The company serves perfusionists, neurologists, neurosurgeons, and other physicians, as well as hospitals, other medical institutions, and healthcare providers.
The company sells its medical devices through a combination of direct sales representatives, agents, and independent distributors.
LivaNova PLC was incorporated in 2015 and is headquartered in London, the United Kingdom.
| Country | United Kingdom |
| Founded | 2015 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 2,900 |
| CEO | Vladimir Makatsaria |
Contact Details
Address: 20 Eastbourne Terrace London, W2 6LG United Kingdom | |
| Phone | 44 20 3325 0660 |
| Website | livanova.com |
Stock Details
| Ticker Symbol | LIA |
| Exchange | Frankfurt Stock Exchange |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Vladimir Makatsaria | Chief Executive Officer |
| Alex Shvartsburg | Chief Financial Officer |
| Lindsey Little | Head of Investor Relations |